Publications by authors named "Laura Boos"

Claim this Profile
C
Comparative cost analysis of a diagnostic multi-omics platform for decision support in advanced cancer - results from the Tumor Profiler Melanoma project.
Tarun Mehra, Dominik Menges, Benedict Gosztonyi, Nicola Miglino, Alexander Ring, Laura Boos

NPJ Precis Oncol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Publisher Correction: Feasibility of multiomics tumor profiling for guiding treatment of melanoma.
Nicola Miglino, Nora C Toussaint, Alexander Ring, Ximena Bonilla, Marina Tusup, Laura Boos

Nat Med· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Feasibility of multiomics tumor profiling for guiding treatment of melanoma.
Nicola Miglino, Nora C Toussaint, Alexander Ring, Ximena Bonilla, Marina Tusup, Laura Boos

Nat Med· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Precision Oncology Guided by Genomic Profiling in Breast Cancer: Real-World Data from a Molecular Tumor Board.
Tim Graf, Laura A Boos, Tarun Mehra, Nicola Miglino, Bettina Sobottka

Cancers (Basel)· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Precision Oncology Program (POP), an observational study using real-world data and imaging mass cytometry to explore decision support for the Molecular Tumor Board: study protocol.
Laura Amanda Boos, Christian Doerig, Gabriele Gut, Nicola Miglino, Luis Fábregas Ibáñez

BMJ Open· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-World Outcomes of Patients With Malignant Pleural Mesothelioma Receiving a Combination of Ipilimumab and Nivolumab as First- or Later-Line Treatment.
Sabine Schmid, Lisa Holer, Katrin Gysel, Kira-Lee Koster, Sacha I Rothschild, Laura A Boos

JTO Clin Res Rep· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A multicenter phase II trial of anti-EGFR-immunoliposomes loaded with doxorubicin in patients with advanced triple negative breast cancer.
Christoph Mamot, Andreas Wicki, Ursula Hasler-Strub, Salome Riniker, Qiyu Li, Laura A Boos

Sci Rep· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adaptive immunity and neutralizing antibodies against SARS-CoV-2 variants of concern following vaccination in patients with cancer: The CAPTURE study.
Annika Fendler, Scott T C Shepherd, Lewis Au, Katalin A Wilkinson, Mary Wu, Laura Amanda Boos

Nat Cancer· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adaptive immunity and neutralizing antibodies against SARS-CoV-2 variants of concern following vaccination in patients with cancer: the CAPTURE study.
Annika Fendler, Scott T C Shepherd, Lewis Au, Katalin A Wilkinson, Mary Wu, Laura Amanda Boos

Nat Cancer· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Functional antibody and T cell immunity following SARS-CoV-2 infection, including by variants of concern, in patients with cancer: the CAPTURE study.
Annika Fendler, Lewis Au, Scott T C Shepherd, Fiona Byrne, Maddalena Cerrone, Laura Amanda Boos

Nat Cancer· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Functional antibody and T-cell immunity following SARS-CoV-2 infection, including by variants of concern, in patients with cancer: the CAPTURE study.
Annika Fendler, Lewis Au, Scott T C Shepherd, Fiona Byrne, Maddalena Cerrone, Laura Amanda Boos

Res Sq· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Oligoprogression After Checkpoint Inhibition in Metastatic Melanoma Treated With Locoregional Therapy: A Single-center Retrospective Analysis.
Francesca Comito, Isla Leslie, Laura Boos, Andrew Furness, Lisa Pickering

J Immunother· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cancer, COVID-19, and Antiviral Immunity: The CAPTURE Study.
Lewis Au, Laura Amanda Boos, Anthony Swerdlow, Fiona Byrne, Scott T C Shepherd

Cell· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Metastatic melanoma: therapeutic agents in preclinical and early clinical development.
Laura Amanda Boos, Isla Leslie, James Larkin

Expert Opin Investig Drugs· July 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Avelumab and axitinib in the treatment of renal cell carcinoma: safety and efficacy.
Isla Leslie, Laura Amanda Boos, James Larkin, Lisa Pickering

Expert Rev Anticancer Ther· May 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
MiRNAs Are Involved in Tall Cell Morphology in Papillary Thyroid Carcinoma.
Laura A Boos, Anja Schmitt, Holger Moch, Paul Komminoth, Cedric Simillion

Cancers (Basel)· June 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Interlaboratory variability of MIB1 staining in well-differentiated pancreatic neuroendocrine tumors.
Annika Blank, Laura Wehweck, Ilaria Marinoni, Laura Amanda Boos, Frank Bergmann

Virchows Arch· November 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Diagnostic and prognostic implications of the PAX8-PPARγ translocation in thyroid carcinomas-a TMA-based study of 226 cases.
Laura A Boos, Matthias Dettmer, Anja Schmitt, Thomas Rudolph, Hans Steinert

Histopathology· August 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
C3a expressed in the central nervous system protects against LPS-induced shock.
Laura Boos, Alexander J Szalai, Scott R Barnum

Neurosci Lett· October 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Murine complement C4 is not required for experimental autoimmune encephalomyelitis.
Laura A Boos, Alexander J Szalai, Scott R Barnum

Glia· January 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Deletion of the complement anaphylatoxin C3a receptor attenuates, whereas ectopic expression of C3a in the brain exacerbates, experimental autoimmune encephalomyelitis.
Laura Boos, Iain L Campbell, Robert Ames, Rick A Wetsel, Scott R Barnum

J Immunol· October 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis